Literature DB >> 7461705

Properties of peritoneal exudate lymphocytes that mediate tuberculin delayed-type hypersensitivity and anti-tuberculosis immunity. I. The effect of cytotoxic agents.

M J Lefford.   

Abstract

Acute peritoneal exudates were raised in rats that had been immunized by BCG, in order to draw into the peritoneal cavity sensitized immunoblasts. The peritoneal exudate cells (PEC) were harvested 24 h after exudate induction. The ability of these cells to confer tuberculin delayed-type hypersensitivity (DTH) and anti-tuberculosis immunity upon syngeneic recipients was examined after treatment with various cytotoxic agents. The transfer of DTH and immunity was entirely unaffected by in vitro exposure of PEC to high specific activity [3H]-thymidine, 5-bromodeoxyuridine or a low dose of mitomycin C. agents that adversely affect DNA-synthetic cells. Treatment of immunized rats with vinblastine reduced the number of PEC, but the cells were able to transfer DTH and immunity. In vitro exposure of PEC to vinblastine ablated the transfer of DTH but spared immunity. A moderate dose of mitomycin C suppressed immunity but not DTH; but a high dose abolished both expressions of cell-mediated immunity. The transfer of immunity was highly susceptible to ionizing radiation whereas DTH was resistant. These results suggest that the lymphocytes mediating DTH and anti-tuberculosis immunity are not actively replicating cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7461705      PMCID: PMC1458132     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Nonspecific entry of thoracic duct immunoblasts into intradermal foci of antigens.

Authors:  A R Moore; J G Hall
Journal:  Cell Immunol       Date:  1973-07       Impact factor: 4.868

2.  In vitro elimination of specific immunoreactive cells with 5-bromodeoxyuridine.

Authors:  D C Zoschke; F H Bach
Journal:  J Immunol Methods       Date:  1971-09       Impact factor: 2.303

3.  Immune response to Mycobacterium tuberculosis in rats.

Authors:  M J Lefford; D D McGregor; G B Mackaness
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

4.  Dissociation of MIF production and cell proliferation.

Authors:  B R Bloom; J Gaffney; L Jimenez
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

5.  Properties of lymphocytes which confer adoptive immunity to tuberculosis in rats.

Authors:  M J Lefford; D D McGregor; G B Mackaness
Journal:  Immunology       Date:  1973-10       Impact factor: 7.397

6.  The role of proliferation in delayed hypersensitivity.

Authors:  J D Feldman
Journal:  J Immunol       Date:  1968-09       Impact factor: 5.422

7.  The effect of radiation upon lymphocyte response to PHA.

Authors:  A B Rickinson; P L Ilbery
Journal:  Cell Tissue Kinet       Date:  1971-11

8.  The effect of irradiation on the passive transfer of delayed hypersensitivity.

Authors:  G L Asherson; G Loewi
Journal:  Immunology       Date:  1967-11       Impact factor: 7.397

9.  Cell populations and cell proliferation in the in vitro response of normal mouse spleen to heterologous erythrocytes. Analysis by the hot pulse technique.

Authors:  R W Dutton; R I Mishell
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

10.  The mediator of cellular immunity. VI. Effect of the antimitotic drug vinblastine on the mediator of cellular resistance to infection.

Authors:  D D McGregor; P S Logie
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

View more
  2 in total

1.  Comparative migration of T- and B-lymphocyte subpopulations into skin inflammatory sites.

Authors:  A C van Dinther-Janssen; A C van Maarsseveen; J de Groot; R J Scheper
Journal:  Immunology       Date:  1983-03       Impact factor: 7.397

2.  Properties of peritoneal exudate lymphocytes that mediate tuberculin delayed-type hypersensitivity and anti-tuberculosis immunity.

Authors:  M J Lefford
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.